Pharm-D Sdn Bhd is proud to announce the launch of Valens Onthera+, a comprehensive immunonutrition supplement drink designed to combat malnutrition in cancer patients. This significant milestone represents years of dedicated research and development, focused on improving patient outcome.
Cancer, along with its treatment regimens like chemotherapy and radiotherapy, can often lead to malnutrition. Valens Onthera+ is a precisely formulated solution to address this critical challenge, while at the same time caters to patients experiencing hypercatabolic states, a condition where the body breaks down muscle tissue at an accelerated rate.
At Pharm-D, we are committed to providing innovative and science-backed medical nutrition solutions. Valens Onthera+ is a testament to this commitment, offering patients the vital nutrients they need to support their recovery.
Pharm-D Health Science (PDHS) is a diversified healthcare group specialising in niche pharmaceuticals, medical nutrition, supplements, and medical devices.
